Facing one of the longest downturns in industry history, LyondellBasell reported Q2 2025 earnings of $0.62 per share, outlining a disciplined strategy focused on cash conservation, portfolio optimization in Europe, and a pivot towards circular and low-carbon solutions to emerge stronger from the cycle.
Exxon Mobil and Chevron reported declines in full-year earnings as a sustained oil surplus pressured prices, though both companies highlighted strategic shifts toward LNG, chemicals, and power projects to fuel future growth.
Gold and silver futures plummeted Friday, erasing recent gains in a dramatic reversal. The sharp decline coincided with broader market jitters and followed warnings that the metals' explosive rally had entered unsustainable territory.
Beazer Homes USA reported a steeper-than-expected quarterly loss, with revenue falling 22% amid a challenging housing market characterized by soft demand and aggressive competitor pricing.
Elon Musk is reportedly in discussions to merge his aerospace giant SpaceX with his artificial intelligence venture xAI, aiming to create an integrated powerhouse for deploying AI data centers in orbit, powered by space solar energy.
Despite posting a Q4 net loss, ArcBest is streamlining operations and investing in technology, positioning for a market rebound while the broader LTL sector continues its slow climb from a prolonged slump.
The doughnut giant has agreed to a multimillion-dollar settlement following a 2024 cyberattack that compromised personal data of current and former staff, though it admits no fault.
Congress has approved $23 billion in initial funding for the ambitious Golden Dome missile defense initiative, yet the absence of a detailed spending blueprint from the Pentagon is stalling progress and clouding investment prospects for 2026.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.
St. Louis Fed President Alberto Musalem argues the current interest rate stance is appropriate, signaling a pause in the central bank's easing cycle unless the labor market weakens or inflation drops unexpectedly.
In a significant policy shift, Chinese authorities have reportedly cleared the AI startup DeepSeek to purchase Nvidia's advanced H200 processors, potentially easing a major hardware bottleneck for its competitive large language model.
From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.
The drive-thru coffee chain 7 Brew debuts a monthly rotating menu of featured beverages, starting with five options for February including a new Chocolate Dipped Strawberry Cold Brew, as it leverages its strong rewards membership to boost visit frequency.
American Express reported fourth-quarter earnings that narrowly missed analyst forecasts, yet a modest stock decline reflects investor confidence in its robust guidance and the sustained momentum of its high-end cardmember base.
Walmart is significantly expanding its electric vehicle charging infrastructure, with planned installations at select stores across 19 states, advancing its goal to build a nationwide network by 2030.
As SpaceX targets a record-shattering IPO for mid-2026, reports indicate Elon Musk is exploring a potential merger with either Tesla or his AI startup, xAI. The move could create a unified tech and industrial behemoth but faces significant regulatory and operational hurdles.
The iconic California-born chain Peet's Coffee is closing 27 locations, including outlets in Manhattan Beach and Redondo Beach, as it navigates post-acquisition restructuring and a challenging market for mid-size coffee retailers.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
Despite lagging the broader market over the past year, Ingersoll Rand shows signs of a strategic pivot. Wall Street sees modest upside potential as the industrial giant navigates headwinds and pursues growth through acquisition.
